Jeff Warnick

Jeff Warnick is a seasoned professional in the pharmaceutical industry with significant expertise in hematology and oncology marketing. Currently serving as Head of US Hematology Sales & Marketing at Amgen since May 2022, Jeff leads a talented team in driving sales and marketing initiatives. Prior to this role, Jeff spent over 15 years at Bristol Myers Squibb, where notable positions included Executive Director and Worldwide Lead for the ABECMA Multiple Myeloma Cell Therapy Franchise and Global Commercial Lead for the IMiD Portfolio. Jeff's career also involved progressive roles in immuno-oncology marketing and sales operations, consistently demonstrating a strong track record in sales growth and marketing strategy execution. Jeff holds a Bachelor of Science degree in Business Management with a focus on Marketing from Brigham Young University - Idaho.